Are there benefits to adding IL5/IL5 receptor blockade in patients with vasculitic manifestations of EGPA?
Community PollStarted
Do you recommend IL5/IL5 receptor blockade in patients with vasculitic manifestations of EGPA?
128 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Rheumatology · The Feinberg School of Medicine, Northwestern University
Answered on
While IL-5/IL5 receptor blockade has been shown to be efficacious in treating "eosinophilic" manifestations of EGPA, including asthma and nasal polyps, there are real-world studies that demonstrate its effectiveness in what we consider "vasculitic" manifestations of the disease as well. I personally...
Join for free or sign in to see the full answer